Banca Mediolanum (MIL:BMED) 5-Year EBITDA Growth Rate

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:BMED Banca Mediolanum MIL:BMED
64 GF Score
Price €23.62
GF Value €10.58
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Banca Mediolanum 5-Year EBITDA Growth Rate?

5-Year EBITDA Growth Rate does not apply to banks.

MIL:BMED
64GF Score
Banca Mediolanum MIL:BMED
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Banca Mediolanum (MIL:BMED) Overvalued in 2026?

Based on GuruFocus' analysis, Banca Mediolanum stock appears to be overvalued. The current stock price of €23.62 is trading 123.3% above its estimated GF Value™ of €10.58. GuruFocus considers Banca Mediolanum to be Significantly Overvalued.

Key valuation signals for MIL:BMED:

  • 5-Year EBITDA Growth Rate:
  • GF Value™: €10.58 vs. price of €23.62 (123.3% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the MIL:BMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Banca Mediolanum Business Description

Address Palazzo Meucci - Via Ennio Doris, Basiglio, ITA, 20079
Banca Mediolanum SpA is an Italian banking and financial services group controlled by the Doris family and headquartered in Basiglio, near Milan. It serves individuals and households through a network of family bankers (financial advisers) rather than traditional branches, offering current accounts, mortgages, loans, payment cards, and securities and investment services. Its insurance subsidiaries underwrite life and non-life policies, including protection and pension products. Asset management is conducted through Mediolanum Gestione Fondi and related companies, distributing mutual funds and portfolio management services. Operations are organized across Italy, Spain, and Germany, with Italy generating the large majority of revenue. Income comes from net interest margin, fees and commissions on banking, investment, and insurance products, plus insurance premiums and investment returns. The company is listed on the Borsa Italiana.
64GF Score

Get the complete analysis for MIL:BMED

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.62
Price
€10.58
GF Value